ATRA Atara Biotherapeutics, Inc.

NASDAQ
$9.71

Atara Biotherapeutics, Inc. (ATRA) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bullish Insiders bought more than they sold over this window — uncommon at any size.
Cluster activity 1 buyer in the last 30 days 1 buyer in the last 90 days 1 seller in the last 90 days
Insiders buying
2
2 transactions
Insiders selling
3
18 transactions
Purchases
$5.7M
611,573 shares
Sales
$3.9M
416,536 shares
Net activity
$1.9M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $3.9M 18 transactions · 416,536 shares

Largest single sale: $3.2M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: September 4, 2026 , by Cherry Brian N .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Cherry Brian N Director Buy 104,166 $9.60 $1000.0K 166,486
Nguyen AnhCo President and CEO Sell 5,062 $8.08 $40.9K 132,775 −3.7% of holding
Nguyen AnhCo President and CEO Sell 5,241 $9.13 $47.8K 137,837 −3.7% of holding
Grant-Huerta Yanina Chief Accounting Officer Sell 2,414 $9.13 $22.0K 49,636 −4.6% of holding
EcoR1 Capital, LLC 10% Owner Buy 507,407 $9.35 $4.7M 1,552,000
Sell 313,446 $10.10 $3.2M 1,011,000 −23.7% of holding
Nguyen AnhCo 4 fills President and CEO Sell 2,996 $5.09 $15.2K 64,776 −4.4% of holding
Grant-Huerta Yanina 4 fills Chief Accounting Officer Sell 2,104 $5.08 $10.7K 33,830 −5.9% of holding
Sell 80,554 $6.07 $489.0K 1,324,446 −5.7% of holding
Nguyen AnhCo 2 fills President and CEO Sell 2,915 $13.19 $38.4K 65,030 −4.3% of holding
Grant-Huerta Yanina 3 fills Chief Accounting Officer Sell 1,804 $13.19 $23.8K 33,613 −5.1% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.